| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 40.2422 | 7 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.1324 | 42 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.3039 | 24 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.5209 | 20 |
| GSM780720 | Untreated after 4 days (C2_2) | 41.5696 | 11 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.199 | 28 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.8591 | 41 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 39.0187 | 4 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.4774 | 15 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.0049 | 37 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 40.6349 | 8 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 39.7982 | 6 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 38.0695 | 3 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.2602 | 38 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.7642 | 40 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.6205 | 50 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 41.0198 | 9 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.7588 | 12 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.3335 | 19 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.6841 | 35 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 56.3042 | 61 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 42.1431 | 14 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.6683 | 35 |